Literature DB >> 15772387

Glucagon-like peptide 2 is an endogenous mediator of postresection intestinal adaptation.

Alexander Perez1, Mark Duxbury, Flavio G Rocha, Anthony P Ramsanahie, Robert S Farivar, Heike Varnholt, Hiromichi Ito, Helen Wong, Jan Rounds, Michael J Zinner, Edward E Whang, Stanley W Ashley.   

Abstract

BACKGROUND: After massive small bowel resection, the remnant intestine undergoes compensatory adaptation. We tested the hypothesis that glucagon-like peptide-2 (GLP-2) is an endogenous mediator of postresection intestinal adaptation.
METHODS: Rats were allocated to 1 of 4 groups: groups 1 and 2 rats underwent mid-small bowel transection and reanastomosis; groups 3 and 4 rats underwent 75% mid-small bowel resection and reanastomosis. Groups 2 and 4 rats were administered 1.8 mg of antirat GLP-2 antibody twice daily beginning immediately after the surgical procedure; groups 1 and 3 rats were administered rabbit serum (control). Ileal specimens were harvested on postoperative day 7.
RESULTS: Ileal mucosa from group 3 animals displayed morphologic and proliferative indices of adaptation. Each of these indices of adaptation was inhibited by GLP-2 immunoneutralization (group 4). Morphologic and proliferative parameters in the ileum from animals that had undergone transection with reanastomosis were unaffected by GLP-2 immunoneutralization.
CONCLUSIONS: These results suggest that GLP-2 is an endogenous mediator of postresection intestinal adaptation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772387     DOI: 10.1177/014860710502900297

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  6 in total

Review 1.  Recent advances in small bowel diseases: Part II.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

2.  Portal milieu and the interplay of multiple antidiabetic effects after gastric bypass surgery.

Authors:  Atanu Pal; David B Rhoads; Ali Tavakkoli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-21       Impact factor: 4.052

Review 3.  Intestinal mucosal adaptation.

Authors:  Laurie Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

4.  Off-Label Teduglutide Therapy in Non-intestinal Failure Patients with Chronic Malabsorption.

Authors:  Alvin T George; Betty H Li; Robert E Carroll
Journal:  Dig Dis Sci       Date:  2019-02-07       Impact factor: 3.199

Review 5.  Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticity.

Authors:  Laurie A Drozdowski; M Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

6.  Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.

Authors:  Matthew C Koopmann; David W Nelson; Sangita G Murali; Xiaowen Liu; Mark S Brownfield; Jens J Holst; Denise M Ney
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 May-Jun       Impact factor: 4.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.